Hollsteen
← CoreWeave

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2022: −$11.0M · 10-K 0001769628-26-000104 filed Mar 2, 2026Equity incl. NCI · Q1 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2023: −$597M · 10-K 0001769628-26-000104 filed Mar 2, 2026Equity incl. NCI · Q1 2024: −$716M · 10-Q 0001769628-25-000014 filed May 15, 2025Equity incl. NCI · Q2 2024: −$1.0B · 10-Q 0001769628-25-000041 filed Aug 13, 2025Equity incl. NCI · Q3 2024: −$344M · 10-Q 0001769628-25-000062 filed Nov 13, 2025Equity incl. NCI · Q4 2024: −$414M · 10-K 0001769628-26-000104 filed Mar 2, 2026Equity incl. NCI · Q1 2025: $1.9B · 10-Q 0001769628-25-000014 filed May 15, 2025Equity incl. NCI · Q2 2025: $2.7B · 10-Q 0001769628-25-000041 filed Aug 13, 2025Equity incl. NCI · Q3 2025: $3.9B · 10-Q 0001769628-25-000062 filed Nov 13, 2025Equity incl. NCI · Q4 2025: $3.3B · 10-K 0001769628-26-000104 filed Mar 2, 2026Equity incl. NCI · Q1 2026: $4.8B · 10-Q 0001769628-26-000222 filed May 8, 2026Equity incl. NCI · Q2 2026: $5.0B · 10-Q 0001769628-26-000366 filed Aug 12, 2026missing−1.0445,024−11Q1 2016Q2 2026Q2 2024
$MEquity incl. NCI · Q2 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2023: −$597M · 10-K 0001769628-26-000104 filed Mar 2, 2026Equity incl. NCI · Q1 2024: −$716M · 10-Q 0001769628-25-000014 filed May 15, 2025Equity incl. NCI · Q2 2024: −$1.0B · 10-Q 0001769628-25-000041 filed Aug 13, 2025Equity incl. NCI · Q3 2024: −$344M · 10-Q 0001769628-25-000062 filed Nov 13, 2025Equity incl. NCI · Q4 2024: −$414M · 10-K 0001769628-26-000104 filed Mar 2, 2026Equity incl. NCI · Q1 2025: $1.9B · 10-Q 0001769628-25-000014 filed May 15, 2025−1.0441,906−597Q2 2023Q1 2025Q2 2024
Q2 2024
−1.044$M
All values (12)
PeriodValue ($M)Status
Q2 20265,024reported
Q1 20264,759reported
Q4 20253,335reported
Q3 20253,878reported
Q2 20252,658reported
Q1 20251,906reported
Q4 2024−414reported
Q3 2024−344reported
Q2 2024−1.044reported
Q1 2024−716reported
Q4 2023−597reported
Q4 2022Noneerror

30 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: equity_total

More metrics for CoreWeave

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
−$1.0B
Period
Q2 2024, ended Jun 30, 2024 · as of Jun 30, 2024 (balance as of date, not a sum)
Source
10-Q, filed Aug 13, 2025 · 0001769628-25-000041
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1−$1.0BAug 13, 202510-Q 0001769628-25-000041reported · confidence 1. · current